European Journal of Chemistry

Synthesis, characterization and preliminary pharmacological evaluation of new non-steroidal anti-inflammatory pyrazoline derivatives



Main Article Content

Monther Faisal Mahdi
Ayad Mohammed Rasheed Raauf
Noor Muneer Mohammed

Abstract

A series of six pyrazoline ring derivatives as a pharmacophore were incorporated to the naproxen; to increase its size were synthesized and preliminarly evaluated as anti-inflammatory agents with expected selectivity toward COX-2 enzyme. In vivo acute anti-inflammatory effects of the final compounds (5a-f) were evaluated in rats using egg-white induced edema model of inflammation. The tested compounds and the reference drug (naproxen) produced significant reduction of paw edema with respect to the effect of control group (propylene glycol 50%, v:v). However, compound 5d and 5e show comparable effect to naproxen at all experimental time while compounds 5a, 5b and 5c produced significantly lower inhibitory effect than naproxen at time 120-240 minutes. Furthermore, compound 5f exert significantly higher paw edema reduction than naproxen at 60-240 min. Also the antibacterial activities of the final compounds were evaluated by Well Diffusion Method. All tested compounds exert significant antibacterial activity against tested Gram positive and Gram negative bacteria in comparison to dimethyl sulfoxide as control group. In comparison the antibacterial results among the tested compound 5e may regard the best one and compound 5c the lower one.


icon graph This Abstract was viewed 2751 times | icon graph Article PDF downloaded 1208 times

How to Cite
(1)
Mahdi, M. F.; Raauf, A. M. R.; Mohammed, N. M. Synthesis, Characterization and Preliminary Pharmacological Evaluation of New Non-Steroidal Anti-Inflammatory Pyrazoline Derivatives. Eur. J. Chem. 2015, 6, 461-467.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Laine, L. Rev. Gastroenterol. Disord. 2004, 4(4), S33-S41.

[2]. Scheiman, J. M. Rev. Gastroenterol. Disord. 2005, 5(2), S39-S49.

[3]. Antonietta, M.; Bernardo, A.; Greco, A.; Minghetti, L. Pharma. 2010, 3, 1949-1964.

[4]. Mizushima, T. Pharma. 2010, 3, 1614-1636.

[5]. Wittine, K.; Benci, K.; Rajic, Z.; Zorc, B.; Kralj, M.; Marjanovic, M.; Pavelic, K.; DeClercq, E.; Andrei, G.; Snoeck, R.; Balzarini, J.; Mintas, M. Eur. J. Med. Chem. 2009, 44(1), 143-151.
http://dx.doi.org/10.1016/j.ejmech.2008.03.037

[6]. Singh, G.; Triadafilopoulos, G. J. Rheumatol. 1999, 56, 18-24.

[7]. Chiroli, V.; Benedini, F. Eur. J. Med. Chem. 2003, 38, 441-446.
http://dx.doi.org/10.1016/S0223-5234(03)00055-2

[8]. Byrno, C. Am. J. Gastroenterol. 2011, 1694-1695.

[9]. John, L.; Linda, V. Curr. Opin. Invest. D 2008, 9(11), 1151-1156.

[10]. Mahdi, M. F; Mohammed, M. H; Jassim, A. A. Molecules 2012, 17, 1751-1763.
http://dx.doi.org/10.3390/molecules17021751

[11]. Seibert, K.; Zhang, Y.; Leahy, K.; Hauser, S.; Masferrer, J.; Isakson, P. Adv. Exp. Med. Biol. 1997, 400, 167-170.
http://dx.doi.org/10.1007/978-1-4615-5325-0_24

[12]. Paloucek, F. P.; Rynn, K. O. In Clinical Toxicology; Ford, M. D., Ed.; WB Saunders, 2001.

[13]. Katzung, B. G. (Ed.), Basic and clinical pharmacology, 9th edition, McGraw-Hill, 2004.

[14]. Claus, S.; Boeglin, E.; Brash, A. Biochem. J. 2005, 385, 57-64.
http://dx.doi.org/10.1042/BJ20041115

[15]. Zidar, N.; Odar, K.; Glavac, D.; Jerse, M. J. Cell. Mole. Med. 2009, 13, 3753-3763.
http://dx.doi.org/10.1111/j.1582-4934.2008.00430.x

[16]. Curtis-Prior, P. The Eicosanoid, 1st edition, John Wiley and Sons, 2004.
http://dx.doi.org/10.1002/0470020628

[17]. Solomon, D. H.; Furst, D. E. S. Afr. Pharm. J. 2009, 8, 18-22.

[18]. Pratico, D.; Dogne, J. M. Circulation 2005, 112, 1073-1079.
http://dx.doi.org/10.1161/CIRCULATIONAHA.104.524231

[19]. Hilario, M.; Terreri, M.; Len, C. J. De Pediatria. 2006, 82(5), 206-212.
http://dx.doi.org/10.1590/S0021-75572006000700011

[20]. Zarraga, I. G. E.; Schwarz, E. R. J. Am. Coll. Cardiol. 2007, 49(1), 1-14.
http://dx.doi.org/10.1016/j.jacc.2006.10.003

[21]. Hawkey, C. J. Lancet 1999, 353, 307 -314.
http://dx.doi.org/10.1016/S0140-6736(98)12154-2

[22]. Bombardier, C.; Laine, L.; Reicin, A.; Shapiro, D.; Burgos-Vargas, R.; Davis, B. New Engl. J. Med. 2000, 343, 1520-1528.
http://dx.doi.org/10.1056/NEJM200011233432103

[23]. Raymond, M. P. J. Am. Osteo. Assos. 2004, 104(11), 19-24.

[24]. Silverman, D. G.; Halaszynski, T.; Sinatra, R.; Luther, M.; Rinder, C. S. Can. J. Anaesth. 2003, 50, 1004-1008.
http://dx.doi.org/10.1007/BF03018363

[25]. Verma, A.; Saraf, S. K. Eur. Med. Chem. 2008, 43(5), 897-905.
http://dx.doi.org/10.1016/j.ejmech.2007.07.017

[26]. Beena, V.; Saleh, N.; Akhr-Eldin, O.; Salma, M. Mol. Biomol. Spectrosc. 2015, 136, 661-671.
http://dx.doi.org/10.1016/j.saa.2014.09.080

[27]. Indorkar, D.; Chourasia, O. P.; Limaye, S. Int. J. Curr. Microbiol. 2015, 4(2), 670-678.

[28]. Caroline, C.; Catherine, M. Eur. J. Med. Chem. 2003, 38, 645-659.
http://dx.doi.org/10.1016/S0223-5234(03)00115-6

[29]. Lee, B.; Kwak, J. H.; Huang, S. W.; Jang, J. Y.; Lim, S.; Kwak, Y. S,; Lee, K.; Kim, H. S.; Han, S. B.; Hong, J. T.; Lee, H.; Song, S.; Seo, S. Y.; Jung, J. K. Bioorg. Med. Chem. 2012, 20(9), 2860-2868.
http://dx.doi.org/10.1016/j.bmc.2012.03.028

[30]. Grosser, T. Thromb. Haemost. 2006, 96, 393-400.

[31]. Asiri, A.; Marwani, H.; Alamry, K.; Al-Amoudi, M.; Khan, S.; El-Daly, S. Int. J. Electrochem. Sci. 2014, 9, 799-809.

[32]. Bakht, M.; Ansari, M. Int. J. Biol. Pharm. All Sci. 2014, 3(5), 705-717.

[33]. Kantharaju; Vommina, V. Indian J. Chem. 2006, 45, 1942-1944.

[34]. Mahdi. M. F.; Raauf, A. M.; Kadhim, F. A. J. Nat. Sci. Res. 2015, 5(6), 21-28.

[35]. Salem, B.; Mahdi, F.; Mohammed, H. Iraqi J. Pharm. Sci. 2009, 18(2), 39.

[36]. Lichtenberger, M.; Dial, E.; Romero, J.; Moore, J. E. Inflammopharmacology 2008, 16, 1-5.
http://dx.doi.org/10.1007/s10787-006-1604-7

[37]. Neli, L.; Yogendra, K.; Berington, M. J. Med. Plan. Res. 2011, 5(5), 859-861.

[38]. Naser, N. H; Mahdi, M. F; Omer, T. N. Iraqi J. Pharma. Sci. 2011, 20(1), 25-32.

[39]. Verma, S.; Anurekh, J.; Jain, A.; Gupta, V. Int. J. Pharm. Biosci. 2010, 1(2), 1-7.

[40]. Meshram, G. G.; Kumar, A.; Rizvi, W.; Tripathi, C. D.; Khan, R. A. J. Trad. Comp. Med. 2015, 1-4.

Supporting Agencies

Department of Pharmaceutical Chemistry, College of Pharmacy, Al-Mustansiriyah University, Baghdad, 10001, Iraq
Most read articles by the same author(s)
TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).